Simplify Asset Management Inc. Sage Therapeutics, Inc. Transaction History

Simplify Asset Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $1.17 Million - $3.43 Million	70,000 Added 139.92%	120,030 $2.47 Million
Q1 2023 May 10, 2023	BUY	$37.27 - $46.57 $1.86 Million - $2.33 Million	50,030 New	50,030 $2.1 Million

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $415M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Simplify Asset Management Inc. with notifications on news.